Workflow
Workhorse Group Reminds Shareholders to Vote Today FOR All Proposals
Globenewswire· 2025-11-06 21:00
CINCINNATI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today mailed a letter to shareholders reminding them to vote today FOR all proposals in connection with Workhorse’s upcoming Annual Meeting on November 12, 2025. Leading independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co. have recognized the compelling ...
Dentsply Sirona Reports Third Quarter 2025 Results
Globenewswire· 2025-11-06 21:00
Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buyGAAP gross margin of 48.8%, GAAP net loss per share of ($2.14)Adjusted gross margin of 52.6%, adjusted EBITDA margin of 18.4%, adjusted EPS of $0.37Revised FY25 outlook Executing its Return-to-Growth action plan to drive improved performance and deliver sustained, profitable growthProvides leadership up ...
Solmate Infrastructure (SLMT) Launches the UAE’s First Performant Solana Validator, Announces Infrastructure Flywheel™ Including Planned RPC and Colocation Services
Globenewswire· 2025-11-06 21:00
More details on the Infrastructure Flywheel™ are available on Solmate’s new website: www.solmate.com. More details on the Infrastructure Flywheel™ are available on Solmate’s new website: www.solmate.com. Validator boasts first-ever Solana block minted in the UAE and is now open to the public at 0% commission Solmate validator to serve as foundation for new RPC and colocation infrastructure services powering DeFi Growing $SOL inventory improves RPC & colocation performance, allowing higher fees to purc ...
For the Second Consecutive Year, Provident Bank Announces $50,000 in Grants to 6 Non-Profit Organizations
Globenewswire· 2025-11-06 21:00
Funding is provided through the FHBNY’s Small Business Recovery Grant ProgramISELIN, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, has announced the organization recently awarded a total of $50,000 in grants to 6 non-profit organizations as part of the Federal Home Loan Bank of New York (FHLBNY) Small Business Recovery Grant (SBRG) Program. The SBRG program provides funds to benefit the small businesses of FHLBNY members, including farms and nonpro ...
Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations Worldwide
Globenewswire· 2025-11-06 21:00
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ8™ Microinverters have been selected for gas station solar projects around the world, helping businesses deploy clean, reliable energy in some of the most safety-critical commercial environments. Enphase microinverters are uniquely suited to gas station installations thanks to t ...
Skyharbour’s Partner Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property
Globenewswire· 2025-11-06 21:00
Vancouver, BC, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that partner company Mustang Energy Corp. (“Mustang”) received the results of a high resolution HTDEM survey at the 914W Uranium Project (the “Project”), totaling 136 line-kms. The Project has road access and is in a prospective region known for its mineral potential south of the Athabasca Basin. The 914W TDEM survey successfully defi ...
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
Globenewswire· 2025-11-06 21:00
- Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines - - New Innovative Licensing and Access Pathway (ILAP) designation provides unique, end-to-end regulatory access pathway for Solid to work directly with the UK’s National Health System (NHS), the UK Medicines and Healthcare products Regulatory Agency (MHRA) and health technology assessment (HTA) bodies: the National Institute for Health and Care Excellence (NICE), the Scottis ...
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
Globenewswire· 2025-11-06 21:00
DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 12, 2025. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title:Humacyte Third Quarter 2025 Financial Results and Corporate UpdateDate:No ...
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
Globenewswire· 2025-11-06 21:00
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address key limitations of targeted RNA-sequencing (RNA-seq) panels in detecting therapeutically-relevant gene rearrangements in acute leukemias. This peer-reviewed publication, entitled “Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene ...
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
Globenewswire· 2025-11-06 21:00
— Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks— —New Clinical Data Provides Insights on Nebokitug’s Direct Macrophage-Mediated Mechanisms that Are Key to PSC Disease Progression— —All Three Presentations Have Been Designated as Posters of Distinction— TEL AVIV, Israel and WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical sta ...